INBRAIN Neuroelectronics Announced Scientific Advisory Board

Company at the intersection of medtech, deeptech, and digital health dedicated to developing the world’s first intelligent graphene-neural platform, today announced the appointment of a Scientific Advisory Board.

The board’s inaugural members include Nobel laureate and graphene pioneer Konstantin Novoselov, Ph.D., FRS, FInstP, FRSC, of the National University of Singapore; artificial intelligence (AI) expert Richard Benjamins, Ph.D., of Telefonica and OdiseIA; renowned neuroscientist David Eagleman, Ph.D., of Stanford University; and Jennifer A. Chandler, LLB, LLM, of the University of Ottawa, a foremost authority on biomedical ethics and their legal implications for neurotech.

The board will use its collective expertise to guide INBRAIN’s vision into the evolution of 2D materials such as graphene in clinical neurotechnology, providing insights on the latest developments in neuroscience, neuroethics, neurorights, and the impact of AI in neurobiology.